O. Legrand
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- Polyomavirus and related diseases
- Drug Transport and Resistance Mechanisms
Papers in
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 1
- Oncology 4
- Cancer Treatment and Pharmacology 1
- Drug Transport and Resistance Mechanisms 1
- Co-authors
- R Zittoun (2 shared papers)Ghislaine Simonin (1 shared paper)Philippe Rousselot (2 shared papers)Anne Vekhoff (2 shared papers)J. P. Marie (2 shared papers)Christophe Bardin (2 shared papers)F. Chast (2 shared papers)Éolia Brissot (1 shared paper)
- Journals
- Leukemia (1 paper)British Journal of Haematology (1 paper)British Journal of Cancer (1 paper)Haematologica (1 paper)La Presse Médicale (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
O. Legrand
7 papers receiving 206 citations
Peers
Comparison fields: 5 of 46
- Hematology 136
- Oncology 89
- Transplantation 7
- Genetics 25
- Public Health, Environmental and Occupational Health 53
Countries citing papers authored by O. Legrand
This map shows the geographic impact of O. Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Legrand more than expected).
Fields of papers citing papers by O. Legrand
This network shows the impact of papers produced by O. Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Legrand. The network helps show where O. Legrand may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Legrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 54 | |
| 2 | 2010 | 49 | |
| 3 | 2006 | 44 | |
| 4 | 1998 | 31 | |
| 5 | 2000 | 25 | |
| 6 | 1999 | 7 | |
| 7 | CEFTAZIDIME : AVANTAGES DES PERFUSIONS CONTINUES CHEZ UN MALADE EN APLASIE | 1993 | 2 |
About O. Legrand
O. Legrand is a scholar working on Hematology, Oncology, Molecular Biology, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine, having authored 7 papers that have together received 212 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Retinoids in leukemia and cellular processes (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Cancer Treatment and Pharmacology (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Hematology (136 citations), Oncology (89 citations), Transplantation (7 citations), Genetics (25 citations) and Public Health, Environmental and Occupational Health (53 citations). O. Legrand has collaborated with scholars based in France, United States and Italy. Frequent co-authors include R Zittoun, Ghislaine Simonin, Philippe Rousselot, Anne Vekhoff, J. P. Marie, Christophe Bardin, F. Chast, Éolia Brissot, Françoise Picard and Simona Lapusan. Their work appears in journals such as Leukemia, British Journal of Haematology, British Journal of Cancer, Haematologica and La Presse Médicale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.